Accelmed Partners — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Click Therapeutics develops, validates, and commercializes software-based prescription medical treatments, including software-enhanced drug products that combine digital therapeutics with pharmacotherapy.
BiotechDigital HealthHealthtechMedical DevicesNew York, US
David B. Klein(Founder and CEO)Randall Stanicky(Executive Officer)David Klein(Executive Officer, Director)
BoardAlex Zisson(Director)Lee Shapiro(Director)inCris De Luca(Director)in
Board seatUri Geiger· per SEC Form D
Co-investorsH.I.G. CapitalH.I.G. HealthBridge PartnersHealth Catalyst CapitalHikma VenturesSanofi VenturesSupernode Ventures+2 more
Developer of a transcatheter InterAtrial Shunt Device to treat congestive heart failure.
BiotechTewksbury, US
George J. Fazio(Executive Officer, Director)Dan B. Curtis(Executive Officer)
BoardPaul LaViolette(Director)inKevin Gillis(Director)inGerald Brunk(Director)inIrit Yaniv(Director)
Board seatUri Geiger· per SEC Form D
Co-investorsLumira VenturesSV Health InvestorsThird Rock Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.